Dissection of the multiple sclerosis associated DR2 haplotype

被引:22
作者
Etzensperger, Ruth [1 ,2 ]
McMahon, Roisin M. [1 ,2 ,3 ]
Jones, E. Yvonne [3 ]
Fugger, Lars [1 ,2 ,4 ]
机构
[1] Univ Oxford, John Radcliffe Hosp, MRC, Human Immunol Unit,Weatherall Inst Mol Med, Oxford OX3 9DS, England
[2] Univ Oxford, John Radcliffe Hosp, Dept Clin Neurol, Weatherall Inst Mol Med, Oxford OX3 9DS, England
[3] Univ Oxford, Div Struct Biol, Oxford OX3 7BN, England
[4] Aarhus Univ Hosp, Inst Clin, Skejby Sygehus, DK-8200 Aarhus N, Denmark
基金
英国医学研究理事会;
关键词
Epistasis; HLA class II; Multiple sclerosis; Protein crystallography; T cells;
D O I
10.1016/j.jaut.2008.04.016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Epidemiological and genetic data have consistently identified associations with HLA class II alleles in many autoimmune diseases. In multiple sclerosis (MS), an autoimmune disease targeting central nervous system (CNS) myelin, the DR2 haplotype (DRB1 *1501, DRB5*0101 and DQB1 *0602) remains the strongest identified genetic risk factor in Caucasians. However, it is hard to tease apart the precise contributions of its constituent individual alleles and their modes of action remain poorly understood, due ill part to the strong linkage disequilibrium in this region. Recent work in humanized mice indicates functional epistatic interactions whereby DRB5*0101 directly modulates the severity of the ensuing disease through activation-induced cell death (AICD) of encephalitogenic T cells which are restricted by DRB1 * 1501. Complementary structural Studies help to explain how these alleles may facilitate thymic escape of autoreactive T cells and contribute to peripheral T cell activation via suboptimal binding interactions and mechanisms of molecular mimicry. Here we discuss the emerging role of the constituent alleles of the DR2 haplotype and our ongoing efforts to uncover the mechanisms by which they influence MS pathogenesis. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:201 / 207
页数:7
相关论文
共 44 条
[1]   A haplotype map of the human genome [J].
Altshuler, D ;
Brooks, LD ;
Chakravarti, A ;
Collins, FS ;
Daly, MJ ;
Donnelly, P ;
Gibbs, RA ;
Belmont, JW ;
Boudreau, A ;
Leal, SM ;
Hardenbol, P ;
Pasternak, S ;
Wheeler, DA ;
Willis, TD ;
Yu, FL ;
Yang, HM ;
Zeng, CQ ;
Gao, Y ;
Hu, HR ;
Hu, WT ;
Li, CH ;
Lin, W ;
Liu, SQ ;
Pan, H ;
Tang, XL ;
Wang, J ;
Wang, W ;
Yu, J ;
Zhang, B ;
Zhang, QR ;
Zhao, HB ;
Zhao, H ;
Zhou, J ;
Gabriel, SB ;
Barry, R ;
Blumenstiel, B ;
Camargo, A ;
Defelice, M ;
Faggart, M ;
Goyette, M ;
Gupta, S ;
Moore, J ;
Nguyen, H ;
Onofrio, RC ;
Parkin, M ;
Roy, J ;
Stahl, E ;
Winchester, E ;
Ziaugra, L ;
Shen, Y .
NATURE, 2005, 437 (7063) :1299-1320
[2]   Selection and fine-tuning of the autoimmune T-CELL repertoire [J].
Anderton, SM ;
Wraith, DC .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (07) :487-498
[3]   Negative selection during the peripheral immune response to antigen [J].
Anderton, SM ;
Radu, CG ;
Lowrey, PA ;
Ward, ES ;
Wraith, DC .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (01) :1-11
[4]   HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course [J].
Barcellos, LF ;
Oksenberg, JR ;
Begovich, AB ;
Martin, ER ;
Schmidt, S ;
Vittinghoff, E ;
Goodin, DS ;
Pelletier, D ;
Lincoln, RR ;
Bucher, P ;
Swerdlin, A ;
Perick-Vance, MA ;
Haines, JL ;
Hauser, SL .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (03) :710-716
[5]   Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis [J].
Barcellos, Lisa F. ;
Sawcer, Stephen ;
Ramsay, Patricia P. ;
Baranzini, Sergio E. ;
Thomson, Glenys ;
Briggs, Farren ;
Cree, Bruce C. A. ;
Begovich, Ann B. ;
Villoslada, Pablo ;
Montalban, Xavier ;
Uccelli, Antonio ;
Savettieri, Giovanni ;
Lincoln, Robin R. ;
DeLoa, Carolyn ;
Haines, Jonathan L. ;
Pericak-Vance, Margaret A. ;
Compston, Alastair ;
Hauser, Stephen L. ;
Oksenberg, Jorge R. .
HUMAN MOLECULAR GENETICS, 2006, 15 (18) :2813-2824
[6]   Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand [J].
Bielekova, B ;
Goodwin, B ;
Richert, N ;
Cortese, I ;
Kondo, T ;
Afshar, G ;
Gran, B ;
Eaton, J ;
Antel, J ;
Frank, JA ;
McFarland, HF ;
Martin, R .
NATURE MEDICINE, 2000, 6 (10) :1167-1175
[7]   3-DIMENSIONAL STRUCTURE OF THE HUMAN CLASS-II HISTOCOMPATIBILITY ANTIGEN HLA-DR1 [J].
BROWN, JH ;
JARDETZKY, TS ;
GORGA, JC ;
STERN, LJ ;
URBAN, RG ;
STROMINGER, JL ;
WILEY, DC .
NATURE, 1993, 364 (6432) :33-39
[8]   Prospective study on the relationship between infections and multiple sclerosis exacerbations [J].
Buljevac, D ;
Flack, HZ ;
Hop, WCJ ;
Hijdra, D ;
Laman, JD ;
Savelkoul, HFJ ;
van der Meché, FGA ;
van Doorn, PA ;
Hintzen, RQ .
BRAIN, 2002, 125 :952-960
[9]  
CarrascoMarin E, 1996, J IMMUNOL, V156, P450
[10]  
COMPSTON DAS, 1976, LANCET, V2, P1261